Zordani Richard A. Jr. bought GALT
January 16, 2026 · Form 4 insider transaction
Zordani Richard A. Jr. bought 60,000 shares of Galectin Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
60,000
Price
$0.00
Total value
N/A
InsiderZordani Richard A. Jr.
RoleDirector
SecurityStock option (right to buy)
Transaction codeA: Grant or award
Transaction dateJanuary 16, 2026
Filing dateJanuary 21, 2026
Shares owned after60,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The stock options were issued pursuant to the Galectin Therapeutics, Inc. 2019 Omnibus Equity Incentive Plan.; The options vest 100% on December 31, 2026.